14:00 - 17:00 - 临床研究与创新合作论坛
- Clinical Research and Innovation Collaboration Forum
14:00 - 14:10 - 开场致辞
- Leadership Remarks
- 张抒扬 中国医药创新促进会会长,北京协和医院院长、党委副书记
- ZHANG Shuyang , Deputy Secretary of the Party Committee & President, Peking Union Medical College Hospital
14:10 - 15:35
- 第一阶段:临床研究:贯穿医药创新全链条
- PART I: Clinical Research: Throughout the Pharmaceutical Innovation Chain
主持人
- 韩晓红 , 北京协和医院临床药理研究中心主任
- HAN Xiaohong , Professor, Director, Clinical Pharmacology Research Center,Peking Union Medical College Hospital
14:10 - 14:30 - 主旨报告1
- Keynote Speech 1
- 临床需求-创新研发的起点和终点
- Clinical Needs - the Starting Point and End Point of Innovative Research and Development
- 李宁 国家癌症中心/中国医学科学院肿瘤医院副院长
- LI Ning , Vice President, Cancer Hospital, Chinese Academy of Medical Sciences(CAMS)
14:30 - 14:50 - 主旨报告2
- Keynote Speech 2
- 以患者为中心的罕见病药物临床研究
- Patient-centered Clinical Study for Rare diseases Drugs
- 韩晓红 北京协和医院临床药理研究中心主任
- HAN Xiaohong , Professor, Director, Clinical Pharmacology Research Center,Peking Union Medical College Hospital
14:50 - 15:35 - 讨论1
- Panel 1
- 打通从临床问题的提出到产品转化的关键难点
- Bridging the critical gap from clinical problem formulation to product translation
主持人 Panel嘉宾 - 刘慧 ,
- LIU Hui ,
- 冯晨 , 高博医疗集团副总裁、上海高博肿瘤医院执行院长
- FENG Chen , Vice President of Gobroad Healthcare Group ,Executive President of Shanghai Gobroad Cancer Hospital
- 沈志荣 , 百济神州副总裁、全球转化研究及转化医学负责人
- SHEN Zhirong , Vice President, Global Head of Translational Discovery, Research and Medicine, BeiGene
15:35 - 17:00
- 第二阶段:转化应用:合作推动患者获益
- PART2:Translational applications: collaborating to drive patient benefits
主持人
- 白桦 , 北京协和医院科研处副处长
- BAI Hua , Department of Scientific Research PUMCH, Vice Director
15:55 - 16:15 - 主旨报告4
- Keynote Speech 4
- 全球年度临床试验开发回顾及亚太地区临床试验发展趋势
- The Annual Clinical Trials Roundup and the Asia-Pacific Clinical Trials Trends
- 周淑华 Citeline首席分析师
- ZHOU Shuhua ,
16:15 - 17:00
- 讨论2
- Panel 2
- 多方协力,走出临床-转化“死亡谷”
- Multi-party efforts to get out of the clinical-translational ‘valley of death’
主持人
Panel嘉宾
- 付鑫 , 深圳微芯生物科技股份有限公司医学事务负责人(肿瘤产品)
- FU Xin , Head Medical Affairs Oncology Shenzhen Chipscreen Biosciences Co., Ltd.
- 张勇 , 醴泽资本创始管理合伙人
- ZHANG Yong , LYZZ Capital, Co-f,ounder,, Managing partner
-
杜洋 , 香港中文大学(深圳)医学院助理院长,新医学研究院 院长
- DU Yang , Assistant Dean of School of Medicine, Director of Institute of New Medicine, the Chinese University of Hong Kong, Shenzhen